Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Conditions
Metastatic Dedifferentiated Liposarcoma · Metastatic Leiomyosarcoma · Metastatic Myxofibrosarcoma · Metastatic Sarcoma · Metastatic Synovial Sarcoma · Metastatic Undifferentiated Pleomorphic Sarcoma · Unresectable Dedifferentiated Liposarcoma · Unresectable Leiomyosarcoma · Unresectable Myxofibrosarcoma · Unresectable Sarcoma · Unresectable Synovial Sarcoma · Unresectable Undifferentiated Pleomorphic Sarcoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Los Angeles General Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Mark Agulnik)USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Contact: Principal Investigator (Mark Agulnik)UCHealth University of Colorado Hospital, Aurora, Colorado, United States
Contact: Principal Investigator (Breelyn A. Wilky)University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
Contact: Principal Investigator (Emily E. Jonczak)University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Daniel J. Olson)UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Daniel J. Olson)University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Daniel J. Olson)Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
Contact: Principal Investigator (H. Catherine Wilbur)National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland, United States
Contact: Principal Investigator (A P. Chen)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Candace L. Haddox)University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Mia C. Weiss)Siteman Cancer Center-South County, St Louis, Missouri, United States
Contact: Principal Investigator (Mia C. Weiss)University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Melissa A. Burgess)UT MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Elise F. Nassif)University of Virginia Cancer Center, Charlottesville, Virginia, United States
Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303Contact: Principal Investigator (Paul V. Viscuse)
Study leads
Candace L Haddox
Principal Investigator
Dana-Farber - Harvard Cancer Center LAO